Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001463509 | SCV001667455 | likely benign | not provided | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004867731 | SCV005514146 | uncertain significance | not specified | 2024-08-20 | criteria provided, single submitter | clinical testing | The c.306C>A (p.N102K) alteration is located in exon 1 (coding exon 1) of the ACACB gene. This alteration results from a C to A substitution at nucleotide position 306, causing the asparagine (N) at amino acid position 102 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |